Dryness beyond the surface: Sjogren’s and the eye
Background: Sjogren’s syndrome is a chronic systemic autoimmune disease characterized by lymphocytic infiltration and progressive destruction of exocrine glands, particularly the lacrimal and…
Keratoconjunctivitis sicca, commonly known as dry eye syndrome, is a condition where the eyes do not produce enough tears or have a poor quality tear film, leading to dryness and discomfort. It often results in symptoms such as a gritty sensation, burning, itching, redness, and sensitivity to light. Causes can include aging, hormonal changes, certain medications, environmental factors (like dry climates or prolonged screen use), autoimmune diseases (such as Sjögren's syndrome), or structural issues with the eyelids or tear glands. Diagnosis involves a comprehensive eye exam, including tests to measure tear production and assess the quality of tears. Management typically includes artificial tears, lifestyle modifications (like using a humidifier or taking breaks from screens), medications to reduce inflammation, and in severe cases, procedures to conserve tears or improve tear production. Managing underlying conditions contributing to dry eye is also crucial for effective treatment.
Background: Sjogren’s syndrome is a chronic systemic autoimmune disease characterized by lymphocytic infiltration and progressive destruction of exocrine glands, particularly the lacrimal and…
Aim: Previous studies assessed the ocular surface integrity and tear stability are climate dependent. Although previous prevalence studies of Keratoconjunctivitis Sicca (KCS) associated with air…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original Keratoconjunctivitis Sicca work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Keratoconjunctivitis Sicca research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Keratoconjunctivitis Sicca track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Keratoconjunctivitis Sicca. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Keratoconjunctivitis Sicca are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Keratoconjunctivitis Sicca track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.